{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:07:09Z","timestamp":1791317229079,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tularemia is a rare zoonotic disease caused by the Gram-negative bacterium <jats:italic>Francisella tularensis<\/jats:italic>. Serology is frequently the preferred diagnostic approach, because the pathogen is highly infectious and difficult to cultivate. The aim of this retrospective study was to determine the diagnostic accuracy of tularemia specific tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The <jats:italic>Serazym<\/jats:italic>\u00aeAnti-<jats:italic>Francisella tularensis<\/jats:italic> ELISA, Serion ELISA <jats:italic>classic Francisella tularensis<\/jats:italic> IgG\/IgM, an in-house ELISA, the VIRapid\u00ae Tularemia immunochromatographic test, an in-house antigen microarray, and a Western Blot (WB) assay were evaluated. The diagnosis tularemia was established using a standard micro-agglutination assay. In total, 135 sera from a series of 110 consecutive tularemia patients were tested.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The diagnostic sensitivity and diagnostic specificity of the tests were VIRapid (97.0% and 84.0%), Serion IgG (96.3% and 96.8%), Serion IgM (94.8% and 96.8%), Serazym (97.0% and 91.5%), in-house ELISA (95.6% and 76.6%), WB (93.3% and 83.0%), microarray (91.1% and 97.9%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The diagnostic value of the commercial assays was proven, because the diagnostic accuracy was &gt;90%. The diagnostic sensitivity of the in-house ELISA and the WB were acceptable, but the diagnostic accuracy was &lt;90%. Interestingly, the antigen microarray test was very specific and had a very good positive predictive value.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-14-234","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T01:02:26Z","timestamp":1399251746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Performance of seven serological assays for diagnosing tularemia"],"prefix":"10.1186","volume":"14","author":[{"given":"Val\u00e9rie","family":"Chaignat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Djordjevic-Spasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Ruettger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Klimpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Araj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Diller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tomaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,5]]},"reference":[{"issue":"4","key":"3148_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/CMR.15.4.631-646.2002","volume":"15","author":"J Ellis","year":"2002","unstructured":"Ellis J, Oyston PC, Green M, Titball RW: Tularemia. Clin Microbiol Rev. 2002, 15 (4): 631-646. 10.1128\/CMR.15.4.631-646.2002.","journal-title":"Clin Microbiol Rev"},{"key":"3148_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1409.009","volume":"1105","author":"A Sjostedt","year":"2007","unstructured":"Sjostedt A: Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007, 1105: 1-29. 10.1196\/annals.1409.009.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3148_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3201\/eid0802.010164","volume":"8","author":"LD Rotz","year":"2002","unstructured":"Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM: Public health assessment of potential biological terrorism agents. Emerg Infect Dis. 2002, 8 (2): 225-230. 10.3201\/eid0802.010164.","journal-title":"Emerg Infect Dis"},{"issue":"21","key":"3148_CR4","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","volume":"285","author":"DT Dennis","year":"2001","unstructured":"Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O\u2019Toole T, Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense: Tularemia as a biological weapon: medical and public health management. JAMA. 2001, 285 (21): 2763-2773. 10.1001\/jama.285.21.2763.","journal-title":"JAMA"},{"issue":"5","key":"3148_CR5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1128\/JCM.01475-09","volume":"48","author":"W Splettstoesser","year":"2010","unstructured":"Splettstoesser W, Guglielmo-Viret V, Seibold E, Thullier P: Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species. J Clin Microbiol. 2010, 48 (5): 1629-1634. 10.1128\/JCM.01475-09.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3148_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1439-0450.2005.00863.x","volume":"52","author":"WD Splettstoesser","year":"2005","unstructured":"Splettstoesser WD, Tomaso H, Al Dahouk S, Neubauer H, Schuff-Werner P: Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques. J Vet Med B Infect Dis Vet Public Health. 2005, 52 (6): 249-261. 10.1111\/j.1439-0450.2005.00863.x.","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"issue":"1","key":"3148_CR7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CDLI.7.1.86-90.2000","volume":"7","author":"R Grunow","year":"2000","unstructured":"Grunow R, Splettstoesser W, McDonald S, Otterbein C, O\u2019Brien T, Morgan C, Aldrich J, Hofer E, Finke EJ, Meyer H: Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin Diagn Lab Immunol. 2000, 7 (1): 86-90.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"3148_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/JCM.38.1.22-26.2000","volume":"38","author":"A Johansson","year":"2000","unstructured":"Johansson A, Berglund L, Eriksson U, Goransson I, Wollin R, Forsman M, Tarnvik A, Sjostedt A: Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol. 2000, 38 (1): 22-26.","journal-title":"J Clin Microbiol"},{"key":"3148_CR9","volume-title":"Epidemic and Pandemic Alert and Response","author":"WHO","year":"2007","unstructured":"WHO: World health organization guidelines on Tularaemia. Epidemic and Pandemic Alert and Response. 2007, Geneva: World Health Organization"},{"issue":"4","key":"3148_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1017\/S0950268805003742","volume":"133","author":"P Schmitt","year":"2005","unstructured":"Schmitt P, Splettstoesser W, Porsch-Ozc\u00fcr\u00fcmez M, Finke EJ, Grunow R: A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia. Epidemiol Infect. 2005, 133 (4): 759-766. 10.1017\/S0950268805003742.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"3148_CR11","first-page":"1008","volume":"11","author":"M Porsch-Ozc\u00fcr\u00fcmez","year":"2004","unstructured":"Porsch-Ozc\u00fcr\u00fcmez M, Kischel N, Priebe H, Splettstoesser W, Finke EJ, Grunow R: Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia. Clin Diagn Lab Immunol. 2004, 11 (6): 1008-1015.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"3148_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/bsp.2004.2.281","volume":"2","author":"JM Rusnak","year":"2004","unstructured":"Rusnak JM, Kortepeter MG, Hawley RJ, Anderson AO, Boudreau E, Eitzen E: Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers. Biosecur Bioterror. 2004, 2 (4): 281-293. 10.1089\/bsp.2004.2.281.","journal-title":"Biosecur Bioterror"},{"issue":"1","key":"3148_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/infdis\/170.1.110","volume":"170","author":"M Ericsson","year":"1994","unstructured":"Ericsson M, Sandstrom G, Sjostedt A, Tarnvik A: Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25\u00a0years after natural infection. J Infect Dis. 1994, 170 (1): 110-114. 10.1093\/infdis\/170.1.110.","journal-title":"J Infect Dis"},{"issue":"1","key":"3148_CR14","first-page":"86","volume":"240","author":"J Bockem\u00fchl","year":"1978","unstructured":"Bockem\u00fchl J, Roth J: Brucella titers in subclinical infections due to Yersinia enterocolitica serotype O:9 in a pig-breeding farm (author\u2019s transl). Zentralbl Bakteriol Orig A. 1978, 240 (1): 86-93.","journal-title":"Zentralbl Bakteriol Orig A"},{"issue":"5","key":"3148_CR15","first-page":"639","volume":"44","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG: Standards for reporting of diagnostic accuracy group: the STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration: the standards for reporting of diagnostic accuracy group. Croat Med J. 2003, 44 (5): 639-50.","journal-title":"Croat Med J"},{"issue":"5","key":"3148_CR16","first-page":"635","volume":"44","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Standards for reporting of diagnostic accuracy group: towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative: the standards for reporting of diagnostic accuracy group. Croat Med J. 2003, 44 (5): 635-8.","journal-title":"Croat Med J"},{"issue":"5","key":"3148_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1128\/CVI.13.5.561-567.2006","volume":"13","author":"MF Anjum","year":"2006","unstructured":"Anjum MF, Tucker JD, Sprigings KA, Woodward MJ, Ehricht R: Use of miniaturized protein arrays for Escherichia coli O serotyping. Clin Vaccine Immunol. 2006, 13 (5): 561-567. 10.1128\/CVI.13.5.561-567.2006.","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"3148_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/00365540410020442","volume":"36","author":"A T\u00e4rnvik","year":"2004","unstructured":"T\u00e4rnvik A, Priebe HS, Grunow R: Tularaemia in Europe: an epidemiological overview. Scand J Infect Dis. 2004, 36 (5): 350-5. 10.1080\/00365540410020442.","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"3148_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1080\/00365540701402970","volume":"39","author":"H Eliasson","year":"2007","unstructured":"Eliasson H, Back E: Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis. 2007, 39 (10): 880-889. 10.1080\/00365540701402970.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"3148_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-198507000-00006","volume":"64","author":"ME Evans","year":"1985","unstructured":"Evans ME, Gregory DW, Schaffner W, McGee ZA: Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore). 1985, 64 (4): 251-269.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3148_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0463.2008.00901.x","volume":"116","author":"M Meric","year":"2008","unstructured":"Meric M, Willke A, Finke EJ, Grunow R, Sayan M, Erdogan S, Gedikoglu S: Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS. 2008, 116 (1): 66-73. 10.1111\/j.1600-0463.2008.00901.x.","journal-title":"APMIS"},{"issue":"1","key":"3148_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/CVI.00516-12","volume":"20","author":"N Sharma","year":"2013","unstructured":"Sharma N, Hotta A, Yamamoto Y, Fujita O, Uda A, Morikawa S, Yamada A, Tanabayashi K: Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay. Clin Vaccine Immunol. 2013, 20 (1): 9-16. 10.1128\/CVI.00516-12.","journal-title":"Clin Vaccine Immunol"},{"key":"3148_CR23","volume-title":"Evaluaci\u00f3n de un nuevo test inmunocromatogr\u00e1fico (Virapid\u00aeTularemia) para el diagn\u00f3stico serol\u00f3gico de tularemia humana","author":"A Cubero Ribas","year":"2011","unstructured":"Cubero Ribas A, Menegotto F, Gonz\u00e1lez Cabrero S, Guti\u00e9rrez P, Bratos P\u00e9rez MA, Delgado JM, Ordu\u00f1a A: Evaluaci\u00f3n de un nuevo test inmunocromatogr\u00e1fico (Virapid\u00aeTularemia) para el diagn\u00f3stico serol\u00f3gico de tularemia humana. 2011, Malaga, Spain."},{"issue":"1","key":"3148_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2012.05.030","volume":"74","author":"S Kili\u00e7","year":"2012","unstructured":"Kili\u00e7 S, Celebi B, Ye\u015filyurt M: Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia. Diagn Microbiol Infect Dis. 2012, 74 (1): 1-5. 10.1016\/j.diagmicrobio.2012.05.030.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3148_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10654-005-5047-z","volume":"21","author":"H Tomaso","year":"2006","unstructured":"Tomaso H, Mooseder G, Dahouk SA, Bartling C, Scholz HC, Strauss R, Treu TM, Neubauer H: Seroprevalence of anti-Yersinia antibodies in healthy Austrians. Eur J Epidemiol. 2006, 21 (1): 77-81. 10.1007\/s10654-005-5047-z.","journal-title":"Eur J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-234\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:45:42Z","timestamp":1630554342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-234","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,5]]},"assertion":[{"value":"2 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"234"}}